Search Results 1171-1180 of 18064 for Lupus

1. Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis - Mayo Clinic

   Note: Overlap with features of SSc, systemic lupus erythematosus, Sjogren's syndrome, or rheumatoid arthritis is allowed if the dominant clinical disease is DM.

2. RenaCARE - Mayo Clinic

   Clinical features and a kidney biopsy diagnosis strongly indicative of a secondary nephropathy (e.g., diabetic nephropathy, lupus nephritis, acute kidney injury) ...

3. Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients with Early-Stage Breast Cancer that was Removed by Surgery - Mayo Clinic

   Participation eligibility · No severely active co-morbidity, defined as follows: · No active systemic lupus, erythematosus, or any history of scleroderma or ...

4. Pembrolizumab and berahyaluronidase alfa-pmph (subcutaneous route) - Side effects & uses - Mayo Clinic

   Immune system problems (eg, Crohn's disease, ulcerative colitis, lupus) or; Nephritis (inflammation of the kidneys) or; Nervous system problems (eg, Guillain ...

5. A Study to Compare Three Chemotherapy Regimens for the Treatment of Patients with Newly- diagnosed Mantle Cell Lymphoma - Mayo Clinic

   Prothrombin time (PT)/international normalized ratio (INR) or partial thromboplastin time (aPTT) in the absence of lupus anticoagulant) < 2 x institutional ...

6. Rem-422, an MYB mRNA Degrader, in Patients With Relapsed/Refractory AML or Higher-Risk MDS - Mayo Clinic

   History or current autoimmune disease requiring systemic treatment (eg, Crohn disease, ulcerative colitis, rheumatoid arthritis, systemic lupus). 33 ...

7. A Study to Evaluate the Effectiveness, Safety and Way in Which the Body Processes REGN3500 in Adults with Moderate-to-Severe Atopic Dermatitis - Mayo Clinic

   ... lupus, inflammatory bowel disease, rheumatoid arthritis, etc.), other severe endocrinological, gastrointestinal, metabolic, pulmonary, or lymphatic diseases ...

8. Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T cells (CABA-201) in Subjects with Systemic Sclerosis - Mayo Clinic

   Systemic sclerosis-like illness or a primary diagnosis of rheumatic AD other than SSc, including but not limited to rheumatoid arthritis, systemic lupus ...

9. A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer - Mayo Clinic

   - Active, known or suspected autoimmune disease, including systemic lupus erythematosus, Hashimotos thyroiditis, scleroderma, polyarteritis nodosa or autoimmune ...

10. Ipilimumab With or Without Talimogene Laherparepvec in Unresected Melanoma - Mayo Clinic

    ... , systemic lupus erythematosus, scleroderma, or other), or history of autoimmune disease that required systemic treatment (ie, use of corticosteroids ...